temazepam glucuronide
- CAS No.
- 3703-53-5
- Chemical Name:
- temazepam glucuronide
- Synonyms
- BA 2826;Temazepam -D-Glucuronide;Temazepam b-D-glucuronide;3-Hydroxydiazepam Glucuronide;Temazepam glucuronide lithium salt;Temazepam-β-D-glucuronide, racemic mixture;"Temazepam-beta-D-glucuronide, racemic mixture";TeMazepaM β-D-Glucuronide, Mixture of DiastereoMers;7-Chloro-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl-D-Glucopyranosiduronic Acid;β-D-Glucopyranosiduronic acid, 7-chloro-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl
- CBNumber:
- CB51380182
- Molecular Formula:
- C22H21ClN2O8
- Molecular Weight:
- 476.87
- MDL Number:
- MFCD02682125
- MOL File:
- 3703-53-5.mol
Last updated:2023-05-15 10:44:01
Melting point | >218°C (dec.) |
---|---|
Boiling point | 793.2±60.0 °C(Predicted) |
Density | 1.62±0.1 g/cm3(Predicted) |
storage temp. | Controlled Substance, -20°C Freezer, Under Inert Atmosphere |
solubility | Methanol (Slightly) |
form | Solid |
pka | 2.77±0.70(Predicted) |
color | White to Off-White |
FDA UNII | Y1E98AMN1E |
SAFETY
Risk and Safety Statements
Symbol(GHS) | GHS09 |
---|---|
Signal word | Warning |
Hazard statements | H400 |
Precautionary statements | P273-P391-P501 |
temazepam glucuronide Preparation Products And Raw materials
Raw materials
Preparation Products
3703-53-5(temazepam glucuronide)Related Search:
3-Hydroxydiazepam Glucuronide
7-Chloro-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl-D-Glucopyranosiduronic Acid
BA 2826
Temazepam -D-Glucuronide
beta-D-Glucopyranosiduronic acid, 7-chloro-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl
TeMazepaM β-D-Glucuronide, Mixture of DiastereoMers
Temazepam glucuronide lithium salt
Temazepam b-D-glucuronide
Temazepam-β-D-glucuronide, racemic mixture
β-D-Glucopyranosiduronic acid, 7-chloro-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl
"Temazepam-beta-D-glucuronide, racemic mixture"
3703-53-5
C22H21ClN2O8
Glucuronides
Heterocycles
Intermediates & Fine Chemicals
Metabolites & Impurities
Pharmaceuticals